The Latest Breaking News on Pharma

Morris & Dickson Co.'s license has been revoked by the US Drug Enforcement Administration (DEA) following a 68-page order by DEA Administrator Anne Milgram on the opioid crisis

The agency says it will strip Morris & Dickson of its license to sell highly addictive painkillers after finding it failed to flag thousands of suspicious orders at the height of the opioid crisis.

Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration’s push for lower drug prices at the pharmacy counter.

A House panel advanced a 2024 budget bill that would block the ability to access the abortion drug via telehealth

The U.S. Drug Enforcement Administration has allowed one of the nation’s largest drug distributors to keep shipping addictive painkillers for nearly four years despite a judge’s recommendation to strip its license for turning a blind eye to thousands of suspicious opioid orders

With the biotech industry experiencing significant growth due to the increasing demand for healthcare solutions, fundamentally sound stocks such as Amicus Therapeutics (FOLD), POINT Biopharma Global (PNT), and Precision BioSciences (DTIL) might have the potential to provide substantial returns for investors and could be valuable portfolio additions this month. Learn…

Investing in healthcare stocks could help hedge against economic downturns. Thus, Johnson & Johnson (JNJ) could be worth buying. However, I think SNDL (SNDL) is best avoided considering its weak fundamentals. Read on.

On April 26, the Union Cabinet approved the National Medical Devices Policy, 2023.Here are the various reasons why it is imporetant

Pharmacists can only dispense maximum of two months’ supply for every prescription as supplier struggles to meet demand